NUVG yields 5000.00% · JNJ yields 2.13%● Live data
📍 NUVG pulled ahead of the other in Year 1
Combined, NUVG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NUVG + JNJ for your $10,000?
HempTech Corporation, a technology company, provides Controlled Environment Agriculture (CEA) solutions with automation and analytical tools for the cultivators of legal industrial hemp and cannabis in the United States. The company's products and solutions include Grow.droid, a self-contained fully-automated platform for growing cannabis; CognetiX, a suite of software solutions that integrates plant and business data into a real-time, distributed grow control platform; Mithra intelligent lighting that is an LED lighting technology for indoor growing facilities; and GROWComm solutions, which is a community comprising engineers, legacy growers, entrepreneurs, market researchers, and industry pioneers to address the needs of the agriculture and cannabis grow industry. Its solutions also include SmartNergy, an energy management and control product for the indoor agriculture industry; SmartSense, a sensor and control product for the agriculture industry that provides sensors and sensor networks for indoor growing facilities; and SPIDer (secure perimeter intrusion detection network) solution that addresses the potential threat facing the cannabis/hemp industry. The company is based in Saint Petersburg, Florida. HempTech Corporation operates as a subsidiary of FutureWorld Corp.
Full NUVG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.